[{"from": "human", "value": "Provide a description of this molecule. [C][N][C][C][N][Branch1][Branch1][C][C][Ring1][=Branch1][/C][=C][/C][=Branch1][C][=O][N][C][=Branch1][Ring2][=N][\\-Ring1][=Branch1][C][N][=C][Branch2][Ring1][C][C][=C][Ring1][Branch2][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][N+1][=Branch1][C][=O][O-1][C][=C][C][=C][C][=C][Ring1][=Branch1][Cl]"}, {"from": "gpt", "value": "The molecule is an imidazobenzodiazepine with anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Loprazolam is recommended as a short-term therapy only, due to adverse events associated with the drug including dependence and withdrawal symptoms. It is a positive modulator of GABA-A receptor that enhances the inhibitory neurotransmission. It is not an FDA-approved drug."}]